Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herman

Showing results (1171-1180 of 1,237) with videos related to

Pageof 124
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life CareMatthew S Ning, Prajnan Das, David I Rosenthal, et al.
Blood|June 29, 2012
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, David M Lucas, Sneha V Gupta, et al.
Annals of Surgical Oncology|August 27, 2021
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic CancerGeorgios Gemenetzis, Alex B Blair, Minako Nagai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2024
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal AdenocarcinomaColin S Hill, Rose Parkinson, Elizabeth M Jaffee, et al.
Annals of Surgical Oncology|January 8, 2015
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution ExperienceShalini Moningi, Avani S Dholakia, Siva P Raman, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic LeukemiaSarah E M Herman, Arnau Montraveta, Carsten U Niemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Advances in Radiation Oncology|December 22, 2021
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern EraJoseph Abi Jaoude, Connor P Thunshelle, Ramez Kouzy, et al.
Journal of the National Cancer Institute. Monographs|November 16, 2017
The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research GapsFarah Z Zia, Oluwadamilola Olaku, Ting Bao, et al.
Pageof 124

Showing results (1171-1180 of 1,237) with videos related to

Sort By:
Pageof 124
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life CareMatthew S Ning, Prajnan Das, David I Rosenthal, et al.
Blood|June 29, 2012
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, David M Lucas, Sneha V Gupta, et al.
Annals of Surgical Oncology|August 27, 2021
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic CancerGeorgios Gemenetzis, Alex B Blair, Minako Nagai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2024
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal AdenocarcinomaColin S Hill, Rose Parkinson, Elizabeth M Jaffee, et al.
Annals of Surgical Oncology|January 8, 2015
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution ExperienceShalini Moningi, Avani S Dholakia, Siva P Raman, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic LeukemiaSarah E M Herman, Arnau Montraveta, Carsten U Niemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Advances in Radiation Oncology|December 22, 2021
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern EraJoseph Abi Jaoude, Connor P Thunshelle, Ramez Kouzy, et al.
Journal of the National Cancer Institute. Monographs|November 16, 2017
The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research GapsFarah Z Zia, Oluwadamilola Olaku, Ting Bao, et al.
Pageof 124